首页 | 本学科首页   官方微博 | 高级检索  
     

4-1BB (CD137) Ligand Enhanced Anti-Tumor Immune Response against Mouse Forestomach Carcinoma In Vivo
引用本文:Li Q,Ai J,Song Z,Liu J,Shan B. 4-1BB (CD137) Ligand Enhanced Anti-Tumor Immune Response against Mouse Forestomach Carcinoma In Vivo[J]. Cellular & molecular immunology, 2008, 5(5): 379-384
作者姓名:Li Q  Ai J  Song Z  Liu J  Shan B
作者单位:[1]Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, China; [2]The Ninth Hospital of Shijiazhuang, Hebei, China; [3]Research Center, The Fourth Hospital of Hebei Medical University, Jiankang Road 12, Shijiazhuang 050011, Hebei, China
摘    要:Cancer occurrence and development has been demonstrated to be associated with escape from immune surveillance, and low eostimulatory molecules expression has been considered as one of the important reasons for cancer evading the immune system. 4-1BB (CD137) is a costimulatory molecule expressed on the surface of activated T cells. Interaction of 4-1BB with its natural ligand (4-1BBL) expressed on antigen presenting cells (APCs) has been shown to amplify T-cell mediated immunity. We therefore examined whether murine cancer cells expressing 4-1BBL could produce antitumor effects in inoculated mice. Mouse forestomach carcinoma (MFC) cells were transfected with 4-1BBL gene (MFC/4-1BBL). The proliferation of the transduced cells in vitro was not different from that of parental cells. However, MFC/4-1BBL cells developed small tumors and induced higher cytotoxicity of tumor infiltration lymphocyte (TIL). Production of cytokines (IFN-γ TNF-α and IL-2) in serum and cytotoxic T lymphocyte (CTL) activity of splenocytes from mice immunized with mitomycin C (MMC)-treated MFC/4-1BBL cells were significantly higher than that from mice immunized with MMC-treated parental MFC and MFC/ pMKITneo cells. These results suggest that modification of cancer cells with 4-1BBL gene can produce antitumor immune responses.

关 键 词:前胃癌  抗肿瘤免疫反应  抗癌抗菌素  4-1BB

4-1BB (CD137) ligand enhanced anti-tumor immune response against mouse forestomach carcinoma in vivo
Li Qiaoxia,Ai Jun,Song Zhenchuan,Liu Jie,Shan Baoen. 4-1BB (CD137) ligand enhanced anti-tumor immune response against mouse forestomach carcinoma in vivo[J]. Cellular & molecular immunology, 2008, 5(5): 379-384
Authors:Li Qiaoxia  Ai Jun  Song Zhenchuan  Liu Jie  Shan Baoen
Affiliation:Qiaoxia Li1,Jun Ai1,Zhenchuan Song1,Jie Liu2 , Baoen Shan1,31Research Center,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,Hebei,China,2The Ninth Hospital of Shijiazhuang
Abstract:Cancer occurrence and development has been demonstrated to be associated with escape from immune surveillance, and Iow costimulatory molecules expression has been considered as one of the important reasons for cancer evading the immune system.4-1BB(CD137)iS a costimulatory molecule expressed on the surface of activated T cells.Interaction of 4-1BB with its natural ligand(4-1BBL)expressed on antigen presenting cells(APCs)has been shown to amplify T-cell mediated immunity.We therefore examined whether murine cancer cells expressing 4-1BBL could produce antitumor effects in inoculated mice.Mouse rorestomach carcinoma(MFC)cells were transfected with 4-1BBL gene MFC/4-1BBL).The proliferation of the transduced cells in vitro was not different from that of parental cells.However,MFC/4-1BBL cells developed small tumors and induced higher cytotoxicity of tumor infiltration lymphocyte(TIL).Production of cytokines(IFN-γ,TNF-αand IL-2)in serum and cytotoxic T lymphocyte(CTL)activity of splenocytes from mice immunized with mitomycin C (MMC)-treated MFC/4-1BBL cells were significantly higher than that from mice immunized with MMC-treated parental MFC and MFC/ pMKITneo cells.These results suggest that modification of cancer cells with 4-1BBL gene can produce antitumor immune responses.
Keywords:4-1BBL  CTL  antitumor  TIL
本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号